Document is current
Any future updates will be listed below
-
Authors
Perera-Bel, Júlia
Hutter, Barbara
Heining, Christoph
Bleckmann, Annalen
Fröhlich, Martina
Fröhling, Stefan
Glimm, Hanno
Brors, Benedikt
Beißbarth, Tim https://orcid.org/0000-0001-6509-2143
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GP1402, 031L0024, 031A429, 031A428)
- License Information
-
More Information
Article History
Received: 30 January 2018
Accepted: 28 February 2018
First Online: 15 March 2018
Ethics approval and consent to participate
: All patient data were obtained following written informed consent under the NCT MASTER trial, an institutional review board-approved clinical sequencing program for younger patients with advanced-stage hematological and oncological diseases across all malignancies. The trial protocol was approved by the Ethics Committee of Heidelberg University. Research within NCT MASTER was conducted in accordance with the Declaration of Helsinki.
: Written informed consent for publication was obtained under the NCT MASTER trial.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
